These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity. Hacksell U; Johansson AM; Arvidsson L; Nilsson JL; Hjorth S; Carlsson A; Wikström H; Sanchez D; Lindberg P J Med Chem; 1984 Aug; 27(8):1003-7. PubMed ID: 6431102 [TBL] [Abstract][Full Text] [Related]
8. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment. Martin-Iverson MT; Yamada N; By AW; Lodge BA J Psychiatry Neurosci; 1991 Dec; 16(5):253-61. PubMed ID: 1686728 [TBL] [Abstract][Full Text] [Related]
9. Indolizidine and quinolizidine derivatives of the dopamine autoreceptor agonist 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP). Bøgesø KP; Arnt J; Lundmark M; Sundell S J Med Chem; 1987 Jan; 30(1):142-50. PubMed ID: 3806591 [TBL] [Abstract][Full Text] [Related]
10. A study of the role of catecholamines in the response to various central stimulants. Sayers AC; Handley SL Eur J Pharmacol; 1973 Jul; 23(1):47-55. PubMed ID: 4147437 [No Abstract] [Full Text] [Related]
11. [Role of central catecholamines in the psychostimulant activity of pyrovalerone]. Fauquet JP; Morel E; Demarty C; Rapin JR Arch Int Pharmacodyn Ther; 1976 Dec; 224(2):325-37. PubMed ID: 1035081 [TBL] [Abstract][Full Text] [Related]
12. Bridged aminotetralins. 4. Resolution of potent analgesics of the bridged aminotetralin type. Freed ME; Potoski JR; Conklin GL; Bell SC J Med Chem; 1976 Apr; 19(4):560-2. PubMed ID: 817026 [No Abstract] [Full Text] [Related]
13. Derivatives of 5-hydroxy-6-methyl-2-aminotetralin. Cannon JG; Koble DL; Long JP; Verimer T J Med Chem; 1980 Jul; 23(7):750-4. PubMed ID: 6249931 [TBL] [Abstract][Full Text] [Related]
14. Amphetamine stereotypies and polyribosomal disaggregation in rats: effects of adrenergic and serotonergic blocking agents. Widelitz MM; Hable CP Psychopharmacology (Berl); 1980; 72(1):109-10. PubMed ID: 6781001 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734. Van der Weide J; De Vries JB; Tepper PG; Horn AS Eur J Pharmacol; 1986 Jun; 125(2):273-82. PubMed ID: 3743637 [TBL] [Abstract][Full Text] [Related]
16. Differential activation by some 2-aminotetralin derivatives of the receptor mechanisms in the nucleus accumbens of rats which mediate hyperactivity and stereotyped biting. Costall B; Naylor RJ; Cannon JG; Lee T Eur J Pharmacol; 1977 Feb; 41(3):307-19. PubMed ID: 556988 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and central dopaminergic effects of N-(4,6-dimethyl-2-pyridinyl)benzamides. Bouhayat S; Piessard S; Le Baut G; Sparfel L; Petit JY; Piriou F; Welin L J Med Chem; 1985 May; 28(5):555-9. PubMed ID: 4039368 [TBL] [Abstract][Full Text] [Related]
18. Syntheses and biological evaluation of 2- and 9-aminobenzonorbornenes as conformationally rigid analogs of amphetamines. Wood LE; Daniels R; Bauer L; Gearien JE J Pharm Sci; 1981 Feb; 70(2):199-204. PubMed ID: 7205227 [TBL] [Abstract][Full Text] [Related]
19. Central dopaminergic actions of YM-14673, a new TRH analogue, in rodents. Yamamoto M; Ozawa Y; Sasamata M; Koshikawa N; Kobayashi M Eur J Pharmacol; 1990 May; 180(2-3):319-24. PubMed ID: 1973117 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the anorectic and motor activity effects of some aminoindanes, 2-aminotetralin and amphetamine in the rat. Mrongovius RI; Bolt AG; Hellyer RO Clin Exp Pharmacol Physiol; 1978; 5(6):635-40. PubMed ID: 719961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]